Cargando…

Why diabetes outpatient clinics should not close during pandemic crises

Detalles Bibliográficos
Autores principales:	Fadini, G. P., Bonora, B. M., Morieri, M. L., Avogaro, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781425/ https://www.ncbi.nlm.nih.gov/pubmed/33398788 http://dx.doi.org/10.1007/s40618-020-01474-4

Ejemplares similares

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells
por: Bonora, Benedetta Maria, et al.
Publicado: (2023)

Prevalence and impact of diabetes among people infected with SARS-CoV-2
por: Fadini, G. P., et al.
Publicado: (2020)

Why science and synchronized swimming should not be Olympic sports
por: Hall, Neil
Publicado: (2012)

Managing diabetes in diabetic patients with COVID: where do we start from?
por: Avogaro, Angelo, et al.
Publicado: (2021)

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study
por: Morieri, M. L., et al.
Publicado: (2023)

Tackling two crises at once
por: Figueres, Christiana, et al.
Publicado: (2020)

Why ophthalmologists should mask: a perspective from Hong Kong
por: Tang, Geoffrey C. H., et al.
Publicado: (2020)

COVID-19 and homelessness: when crises intersect
por: Baggett, Travis P, et al.
Publicado: (2021)

COVID and the convergence of three crises in Europe
por: Bozorgmehr, Kayvan, et al.
Publicado: (2020)

The importance for tuberculosis of mitigating economic crises
por: Rasella, Davide, et al.
Publicado: (2022)

Reticulocyte parameters: why should clinical laboratories evaluate and report them?
por: Proto-Siqueira, Rodrigo
Publicado: (2014)

REACTing: the French response to infectious disease crises
por: Delfraissy, Jean-François, et al.
Publicado: (2016)

Open questions: why should we care about ER-phagy and ER remodelling?
por: Dikic, Ivan
Publicado: (2018)

Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice
por: Avogaro, Angelo, et al.
Publicado: (2016)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
por: Bonora, B. M., et al.
Publicado: (2021)

Gender and the COVID-19 pandemic: Multinational research indicate that we must support and compensate LMIC women's leadership in crises
por: Raj, Anita
Publicado: (2022)

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
por: Bonora, Benedetta Maria, et al.
Publicado: (2020)

The importance of sharing global forest data in a world of crises
por: Liang, Jingjing, et al.
Publicado: (2020)

Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care
por: Morieri, Mario Luca, et al.
Publicado: (2022)

Why we still need a pandemic treaty
por: Hannon, Elliot, et al.
Publicado: (2022)

The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises
por: Nott, David
Publicado: (2020)

Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic
por: Chen, Paul Z, et al.
Publicado: (2021)

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
por: Bonora, Benedetta Maria, et al.
Publicado: (2020)

Response to Chia Siang Kow and colleagues
por: Avogaro, Angelo, et al.
Publicado: (2022)

How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
por: Bonora, Benedetta Maria, et al.
Publicado: (2019)

Why Treat Insomnia?
por: Perlis, Michael L., et al.
Publicado: (2021)

An urgent need for COP27: confronting converging crises
por: Falk, Jim, et al.
Publicado: (2022)

Why are people with intellectual disabilities clinically vulnerable to COVID-19?
por: Kuper, Hannah, et al.
Publicado: (2023)

Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021)

Why compliance and driving pressure may be inappropriate targets for PEEP setting during ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2022)

Why we need a single independent international hypertension clinical practice guideline
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2021)

COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
por: Danne, Thomas, et al.
Publicado: (2020)

Care coordination in pediatrics: Experience of the outpatient clinic for Children with Special Health Care Needs (CSHCN)
por: Ferrer, Ana Paula Scoleze, et al.
Publicado: (2022)

Why monitor the neonatal brain—that is the important question
por: Vanhatalo, Sampsa, et al.
Publicado: (2022)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fhpkibt1bnvi6heos3iubf4nrr